SF3B1 and B-cell chronic lymphocytic leukemia: Similarly, the anti-proliferative potential of Spliceostatin A corresponding to the inhibition of the splicing process or spliceosome complex (SF3B1) has been observed in breast cancer (mutant cell lines), cervical cancers and chronic lymphocytic leukemia [107,110,111].